- Home
- CODX vs ADXN Comparison
CODX vs ADXN Comparison
Compare CODX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- ADXN
- Stock Information
- Founded
- CODX 2013
- ADXN 2002
- Country
- CODX United States
- ADXN Switzerland
- Employees
- CODX N/A
- ADXN N/A
- Industry
- CODX Medical/Dental Instruments
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- ADXN Health Care
- Exchange
- CODX Nasdaq
- ADXN Nasdaq
- Market Cap
- CODX 9.8M
- ADXN 8.1M
- IPO Year
- CODX 2017
- ADXN N/A
- Fundamental
- Price
- CODX $0.28
- ADXN $9.00
- Analyst Decision
- CODX Buy
- ADXN Strong Buy
- Analyst Count
- CODX 2
- ADXN 1
- Target Price
- CODX $5.50
- ADXN $30.00
- AVG Volume (30 Days)
- CODX 462.7K
- ADXN 7.6K
- Earning Date
- CODX 08-07-2025
- ADXN 06-19-2025
- Dividend Yield
- CODX N/A
- ADXN N/A
- EPS Growth
- CODX N/A
- ADXN N/A
- EPS
- CODX N/A
- ADXN 0.10
- Revenue
- CODX $3,497,583.00
- ADXN $278,508.00
- Revenue This Year
- CODX N/A
- ADXN $86.57
- Revenue Next Year
- CODX $42.11
- ADXN N/A
- P/E Ratio
- CODX N/A
- ADXN $0.74
- Revenue Growth
- CODX N/A
- ADXN N/A
- 52 Week Low
- CODX $0.23
- ADXN $6.51
- 52 Week High
- CODX $2.23
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- CODX 43.19
- ADXN 55.39
- Support Level
- CODX $0.26
- ADXN $8.02
- Resistance Level
- CODX $0.29
- ADXN $9.78
- Average True Range (ATR)
- CODX 0.02
- ADXN 0.73
- MACD
- CODX 0.00
- ADXN 0.02
- Stochastic Oscillator
- CODX 26.83
- ADXN 32.94
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.